| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/20/2002 | US20020077333 For therapy inflammation, inflammatory diseases, immunologic diseases and other diseases mediated by tumor necrosis factor-alpha (TNF-alpha) and/or interleukin 6 or 10 and/or enzyme cyclooxygenase-2 (COX-2) |
| 06/20/2002 | US20020077329 EP4 receptor inhibitors to treat rheumatoid arthritis |
| 06/20/2002 | US20020077305 Genetic immunization with cationic lipids |
| 06/20/2002 | US20020077304 Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds |
| 06/20/2002 | US20020077288 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 06/20/2002 | US20020076812 Generation of pluripotent cells; obtain cells, incubate with modulator, monitor gene expression in cells |
| 06/20/2002 | US20020076796 2786, a novel human aminopeptidase |
| 06/20/2002 | US20020076793 Interleukin-1 beta converting enzyme like apoptosis protease-3 and 4 |
| 06/20/2002 | US20020076705 Nucleotide sequences which code preferential polypeptide; for use in the detection, treatment, and prevention of alzheimer's, parkinson's, huntington's, Tourette Syndrome, meningitis, encephalitis, congenital disorders and brain |
| 06/20/2002 | US20020076420 For preventing the activation of these cells during an allergic response |
| 06/20/2002 | US20020076418 Use of strains of parapoxvirus ovis against organ fibrosis |
| 06/20/2002 | US20020076416 Chimeric peptide immunogens |
| 06/20/2002 | US20020076399 Treatment of immune diseases |
| 06/20/2002 | US20020076392 Non-antibody immunomodulatory molecules such as cytokines expressed as membrane-bound fusion proteins; vaccines; immunotherapy |
| 06/20/2002 | DE10060809A1 Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker Substituted anthranilic acids, their use as a medicament or diagnostic, and she containing drug, as well as a pharmaceutical combination preparation with a sodium / hydrogen exchange (NHE) blockers |
| 06/20/2002 | CA2432736A1 Silenced anti-cd28 antibodies and use thereof |
| 06/20/2002 | CA2431858A1 Targeted enzymes comprising substrate recognition sites and target binding sites |
| 06/20/2002 | CA2431852A1 Herbal pharmaceutical compositions for treating immunological disorders |
| 06/20/2002 | CA2431716A1 Targeted enzyme prodrug therapy |
| 06/20/2002 | CA2431406A1 Quinazolinone derivatives |
| 06/20/2002 | CA2430972A1 Fibrin fragments for treating inflammation |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430899A1 Glycoprotein peptide of the human herpesvirus-7 for use in particular in an elisa serologic test |
| 06/20/2002 | CA2430297A1 Interferon-alpha induced gene |
| 06/20/2002 | CA2430151A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | CA2429952A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | CA2429352A1 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214942A2 Use of dendritic cells, loaded with bacteriophages which carry a tumour-specific and/or tumour-associated antigen on their surface, for treatment of tumours |
| 06/19/2002 | EP1214937A2 Terfenadine carboxylate and the treatment of dermal irritation |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214416A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214350A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 06/19/2002 | EP1214344A1 Dipeptidyl peptidases |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214341A1 Dendritic cell membrane protein fire |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214322A2 Amino-triazolopyridine derivatives |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214292A1 Tyrosine derivatives |
| 06/19/2002 | EP1214095A1 Use of anionic amino acid based surfactants to enhance antimicrobial effectiveness of topical pharmaceutical compositions |
| 06/19/2002 | EP1214090A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214072A2 Use of desloratadine for treating allergic and inflammatory conditions |
| 06/19/2002 | EP1214071A2 Treating allergic and inflammatory conditions using desloratadine |
| 06/19/2002 | EP1214053A1 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 06/19/2002 | EP1105395B1 Photocyclized rapamycins |
| 06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
| 06/19/2002 | EP0892643B1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 06/19/2002 | EP0877619B1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions |
| 06/19/2002 | EP0866691B1 Sublingual and buccal administration of selegiline |
| 06/19/2002 | EP0814831B1 Medicaments for treatment of autoimmune diseases using interferon-tau |
| 06/19/2002 | CN1354750A Amine derivatives compounds |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354668A Isolated peptides which bind to HLA-B35 molecules |
| 06/19/2002 | CN1354663A Sulfonamide and sulfamide substituted imidazoquinolines |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1353991A Ginsenoside enteric tablet |
| 06/19/2002 | CN1353985A Matter or composition for treatment of cancer |
| 06/19/2002 | CN1353946A Cotyledon malacophylla tea and its function |
| 06/18/2002 | US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants |
| 06/18/2002 | US6407140 Autoimmune diseases, graft versus host disease and organ transplant surgery; pyrazole derivative mixture |
| 06/18/2002 | US6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 06/18/2002 | US6407108 1,2,4-triazolo(4,3-b)pyrido(3,2-d)pyridazine derivatives and pharmaceutical compositions containing them |
| 06/18/2002 | US6407092 Tetracyclic azepinoindole compounds |
| 06/18/2002 | US6407080 N-(pyrimidinyl)-aspartic acid analogs as interleukin-1β converting enzyme inhibitors |
| 06/18/2002 | US6406885 Plant cell transformation vectors and dna code intimin |
| 06/18/2002 | US6406865 Method of inhibiting interaction of cells bearing CCR2 by Anti-CCR2 amino-terminal domain antibodies |
| 06/18/2002 | US6406702 Multivalent in ovo avian vaccine |
| 06/18/2002 | US6406696 Activation of t cells, immunopotentiation and immunology, administering anti-cd3 monoclonal antibodies |
| 06/18/2002 | US6406694 Anti-CCR2 antibodies |
| 06/18/2002 | US6406681 Propellents and drugs |
| 06/18/2002 | CA2356812A1 Tnf-alpha production inhibitor comprising kavalactone as an active ingredient |
| 06/18/2002 | CA1341370C Fused polycyclic compounds, methods of manufacture, and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| 06/13/2002 | WO2002046749A2 Screening method for identifying compounds that selectively induce interferon alpha |
| 06/13/2002 | WO2002046426A2 Polypeptide sequences of drug metabolizing enzymes and polynucleotide sequences coding therefor |
| 06/13/2002 | WO2002046418A2 Lipid-associated molecules |
| 06/13/2002 | WO2002046409A2 Proteins and nucleic acids encoding same |
| 06/13/2002 | WO2002046401A1 Use of cells derived from embryonic stem cells for increasing transplantation tolerance and for repairing damaged tissue |
| 06/13/2002 | WO2002046385A2 Enzymes |
| 06/13/2002 | WO2002046384A2 Kinases and phosphatases sequences, and use thereof |
| 06/13/2002 | WO2002046383A2 Protein modification and maintenance molecules |
| 06/13/2002 | WO2002046382A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 06/13/2002 | WO2002046230A2 G-protein coupled receptors |
| 06/13/2002 | WO2002046220A2 Sequences upstream of the carp gene, vectors containing them and uses thereof |
| 06/13/2002 | WO2002046214A2 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2002 | WO2002046208A2 Method of producing biospecific molecules by protein trans-splicing |
| 06/13/2002 | WO2002046197A1 Macroheterocylic compounds useful as kinase inhibitors |
| 06/13/2002 | WO2002046193A2 Heterocyclic ether substituted imidazoquinolines |
| 06/13/2002 | WO2002046192A2 Thioether substituted imidazoquinolines |
| 06/13/2002 | WO2002046191A2 Urea substituted imidazoquinoline ethers |
| 06/13/2002 | WO2002046190A2 Sulfonamido ether substituted imidazoquinolines |